Edition:
United Kingdom

Calumet Specialty Products Partners LP (CLMT.OQ)

CLMT.OQ on NASDAQ Stock Exchange Global Select Market

7.45USD
9:00pm BST
Change (% chg)

$0.15 (+2.05%)
Prev Close
$7.30
Open
$7.40
Day's High
$7.60
Day's Low
$7.30
Volume
49,798
Avg. Vol
45,330
52-wk High
$9.93
52-wk Low
$3.80

Latest Key Developments (Source: Significant Developments)

Calumet Specialty Products Partners Q1 Limited Partners' Interest Net Loss Per Unit $0.06
Tuesday, 15 May 2018 

May 15 (Reuters) - Calumet Specialty Products Partners LP ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. REPORTS FIRST QUARTER 2018 RESULTS.CALUMET SPECIALTY PRODUCTS PARTNERS LP QTRLY LIMITED PARTNERS' INTEREST BASIC AND DILUTED NET LOSS PER UNIT $0.06.CALUMET SPECIALTY PRODUCTS PARTNERS LP - FOR FY 2018, CONTINUES TO ANTICIPATE TOTAL CAPEX WITHIN RANGE OF $80 TO $90 MILLION.CALUMET SPECIALTY PRODUCTS PARTNERS LP QTRLY SALES $750.5 MILLION VERSUS $886.5 MILLION.  Full Article

Calumet Specialty Products Partners Announces The Acquisition Of Biosynthetic Technologies
Monday, 9 Apr 2018 

April 9 (Reuters) - Calumet Specialty Products Partners LP ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. ANNOUNCES THE ACQUISITION OF BIOSYNTHETIC TECHNOLOGIES, LLC, ENHANCING THE TECHNOLOGICAL CAPABILITIES OF THE SPECIALTY PRODUCTS BUSINESS.  Full Article

Calumet Specialty Products Partners Q4 Loss Per Share $0.56 Excluding Items
Monday, 2 Apr 2018 

April 2 (Reuters) - Calumet Specialty Products Partners LP ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. REPORTS REVISED FOURTH QUARTER AND YEAR END 2017 RESULTS.Q4 LOSS PER SHARE $0.56 EXCLUDING ITEMS.Q4 EARNINGS PER SHARE VIEW $-0.56 -- THOMSON REUTERS I/B/E/S.FOR FISCAL 2018, TOTAL CAPITAL SPENDING IS EXPECTED TO BE BETWEEN $80 MILLION AND $90 MILLION.  Full Article

Calumet Specialty Products Partners Files For Non-Timely 10-K With The U.S. SEC
Monday, 19 Mar 2018 

March 19 (Reuters) - Calumet Specialty Products Partners Lp ::CALUMET SPECIALTY PRODUCTS PARTNERS FILES FOR NON-TIMELY 10-K WITH THE U.S. SEC.CALUMET SPECIALTY PRODUCTS PARTNERS LP SAYS EXPECT DECREASE IN PREVIOUSLY REPORTED NET INCOME AND ADJUSTED EBITDA FOR Q4.  Full Article

Calumet Specialty Products Partners Expects Revisions To Previously Announced 2017 Fourth Quarter And Full Year Results
Monday, 19 Mar 2018 

March 19 (Reuters) - Calumet Specialty Products Partners Lp ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. EXPECTS REVISIONS TO PREVIOUSLY ANNOUNCED 2017 FOURTH QUARTER AND FULL YEAR RESULTS.CALUMET SPECIALTY PRODUCTS PARTNERS - PARTNERSHIP DOES NOT ANTICIPATE PREVIOUSLY REPORTED REVENUES, LIQUIDITY FOR QUARTER WILL CHANGE MATERIALLY.CALUMET SPECIALTY PRODUCTS PARTNERS - SEES DECREASE IN REPORTED NET INCOME, ADJUSTED EBITDA FOR Q4 WITH COMMENSURATE DECREASE IN THOSE FOR FY 2017.CALUMET SPECIALTY PRODUCTS PARTNERS - IMPLEMENTATION, LEARNING PROCESS RELATED TO NEW ENTERPRISE RESOURCE PLANNING SYSTEM LED TO THE DEVELOPMENT.  Full Article

Calumet Specialty Products Partners, L.P. Announces Redemption Of All Of Its 11.5% Senior Secured Notes Due 2021
Thursday, 8 Mar 2018 

March 8 (Reuters) - Calumet Specialty Products Partners Lp ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. ANNOUNCES REDEMPTION OF ALL OF ITS 11.5% SENIOR SECURED NOTES DUE 2021.CALUMET SPECIALTY PRODUCTS PARTNERS LP - ‍EXTENDED ITS CORPORATE REVOLVER FOR A NEW FIVE-YEAR TERM​.CALUMET - CO, UNIT CALLED FOR REDEMPTION OF ALL $400 MILLION PRINCIPAL AMOUNT OF OUTSTANDING 11.5% SENIOR SECURED NOTES DUE 2021​.  Full Article

Calumet Specialty Products Partners Reports Qtrly Sales $883.8 Mln Vs. $909.8 Mln‍​
Thursday, 8 Mar 2018 

March 8 (Reuters) - Calumet Specialty Products Partners Lp ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. REPORTS FOURTH QUARTER AND YEAR END 2017 RESULTS.CALUMET SPECIALTY PRODUCTS PARTNERS LP - QTRLY SALES $883.8 MILLION VERSUS $909.8 MLN‍​.CALUMET SPECIALTY PRODUCTS PARTNERS LP - QTRLY LIMITED PARTNERS' INTEREST BASIC AND DILUTED NET LOSS $0.82 PER UNIT.CALUMET SPECIALTY PRODUCTS PARTNERS LP - FOR FISCAL 2018, TOTAL CAPITAL SPENDING IS EXPECTED TO BE BETWEEN $80 MILLION AND $90 MILLION‍​.  Full Article

Calumet Specialty Products Partners Reports Q3 2017 Results
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - Calumet Specialty Products Partners LP ::CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. REPORTS THIRD QUARTER 2017 RESULTS.CALUMET SPECIALTY PRODUCTS PARTNERS LP - QTRLY LIMITED PARTNERS' INTEREST BASIC AND DILUTED NET LOSS PER UNIT $0.30.CALUMET SPECIALTY PRODUCTS PARTNERS LP - QTRLY SALES $1097.4 MILLION VERSUS $966.6 MILLION.CALUMET SPECIALTY PRODUCTS PARTNERS LP SAYS LOWERED FY 2017 CAPITAL SPENDING FORECAST TO BETWEEN $85 TO $95 MILLION.  Full Article

Calumet Specialty Products says lenders consented to postpone due date for 3Q financial statements
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Calumet Specialty Products Partners Lp :Calumet specialty products partners - lenders consented in writing to postpone due date for delivery of 3Q financial statements until Dec 5​.Calumet Specialty Products Partners Lp - ‍failure to deliver unaudited Q3 financial statements by Dec 5 will constitute an event of default​.  Full Article

Calumet Specialty Products to delay reporting Q3 results
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Calumet Specialty Products Partners Lp -:Calumet Specialty Products Partners, L.P. To delay reporting on third quarter financial results.Calumet Specialty Products Partners Lp sees ‍q3 sales above $1,000 million​.Calumet Specialty Products Partners Lp sees ‍Q3 liquidity; revolver availability plus cash, above $400 million​.Q3 revenue view $872.3 million -- Thomson Reuters I/B/E/S.Calumet Specialty Products Partners Lp - ‍ is currently in later stages of an ERP system implementation, results of which have delayed form 10-Q filing​.  Full Article

EXCLUSIVE-Chevron, Exxon seek 'small refinery' waivers from US biofuels law

NEW YORK, April 12 Global energy giants Chevron Corp and Exxon Mobil have asked U.S. regulators for exemptions to the nation's biofuels policy that have historically been reserved for small companies in financial distress, according to sources familiar with the matter.